During the past decade, Spalding Oncology Services conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spalding Oncology Services" #1 collaborator was "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator, "Mena, Raul, M.D." with 1 trials as a collaborator and "Pharmatech Oncology" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Spalding Oncology Services" are "Anemia" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Spalding Oncology Services" in a lesser frequency.

Most popular intervention types in "Spalding Oncology Services" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Cetuximab" (1 trials), "Fluorouracil" (1 trials), "Leucovorin" (1 trials) and "Nipent, Cytoxan, Rituxan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spalding Oncology Services" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Spalding Oncology Services". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Spalding Oncology Services, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Spalding Oncology Services, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".